This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus
Arthritis Research & Therapy Open Access 02 May 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Doria A et al. (2006) Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 119: 700–706
Doria A et al. (2004) Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants. Rheumatology (Oxford) 43: 1580–1586
Doria A and Briani C (2008) Lupus: improving long-term prognosis. Lupus 17: 166–170
Doria A et al. (2008) Preventive strategies in systemic lupus erythematosus. Autoimmun Rev 7: 192–197
James JA et al. (2007) Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus. Lupus 16: 401–409
Conti F et al. (2007) Vaccination and rheumatic diseases: is there still a dilemma? Curr Rheumatol Rev 3: 79–91
Doria A et al. (2008) Challenges of lupus pregnancies. Rheumatology (Oxford) 47 (Suppl 3): iii9–iii12
Arnson Y et al. (2007) Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 66: 1137–1142
Lafyatis R et al. (2006) Antimalarial agents: closing the gate on Toll-like receptors? Arthritis Rheum 54: 3068–3070
Marshak-Rothstein A (2006) Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6: 823–835
Bizzarro N et al. (2007) Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study. J Thromb Haemost 5: 1158–1164
Lim W et al. (2006) Management of antiphospholipid antibody syndrome: a systematic review. JAMA 295: 1050–1057
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Doria, A., Briani, C. Primary prevention of systemic lupus erythematosus. Nat Rev Rheumatol 4, 576–577 (2008). https://doi.org/10.1038/ncprheum0899
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0899
This article is cited by
-
New therapeutic strategies in systemic lupus erythematosus management
Nature Reviews Rheumatology (2019)
-
Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus
Arthritis Research & Therapy (2018)
-
Protective molecules and their cognate antibodies: new players in autoimmunity
Autoimmunity Highlights (2010)